Fábio M. Iwamoto

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao, Andrew Chen, Robyn D. Gartrell et al. · Nature Medicine · 2019 · 918 citations

Neuro-oncology, Tumor Immunology, Anti-pd-1 Immunotherapy +13

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce et al. · Blood · 2017 · 454 citations · Full text

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

Philip H. Gutin, Fábio M. Iwamoto, Kathryn Beal et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 371 citations

Neuro-oncology, Health Sciences, Radiation Therapy +9